vland health company advantages banner
You are here: Home » About Us » Why Choose Us

Healthy Farming, Five-Star Prevention and Control

Vland Animal Health is committed to the R&D and manufacturing of high-quality animal health products, dedicated to providing comprehensive solutions for healthy farming:

Vland Vaccines: Technological Innovation as the Core Competitiveness

Vland Vaccines (Qingdao Vland Animal Health Group Co., Ltd.) leverages internationally advanced processes for antigen industrialization:
 Adopting large-scale suspension cell culture technology
 High-efficiency expression technology for subunit vaccine antigens
 Industrial-grade high-density bacterial fermentation technology

These cutting-edge antigen manufacturing technologies ensure high-quality antigen production for animal vaccines, enabling cost-effective, high-content incorporation of core active ingredients. This approach enhances clinical immunization efficacy, delivering exceptional cost-performance and industry competitiveness.

Sophisticated Manufacturing with Advanced Equipment and Process

 Purification Process: Equipped with imported homogenizers, German GEA cryogenic centrifuges, and ultrafiltration/chromatography purification systems to ensure complete antigen release, thorough removal of impurity proteins, high antigen purity and concentration, minimizing clinical side effects and maximizing protective efficacy.
 Emulsification Process: Utilizes German high-shear dispersion emulsifiers to achieve uniform particle size, stable product properties, easy injectability, and rapid absorption.
 Freeze-Drying Process: Employs Tofflon's fully automated washing, drying, sterilization, filling, and stoppering freeze-drying systems under Class A clean environments to prevent external contamination, ensuring product purity and minimal antigen loss during lyophilization.
 Quality Control: Features automated light inspection and packaging systems for real-time, bottle-by-bottle monitoring of physical properties, foreign particles, and packaging integrity, ensuring product consistency.

Vland Vaccines holds over 30 product approval licenses for animal vaccines and antibodies, with a well-structured and diverse product portfolio

 Poultry Vaccines: Including core products such as Combined Newcastle Disease and Infectious Bronchitis Live Vaccine, Combined Newcastle Disease and Avian Influenza Inactivated Vaccine, Duck Plague Live Vaccine, and Duck Viral Hepatitis Live Vaccine.
 Swine Vaccines: Featuring Classical Swine Fever, Pseudorabies, Porcine Circovirus, Transmissible Gastroenteritis, and Porcine Epidemic Diarrhea vaccines.

KDN Animal Pharmaceutical

Thousands of Formulations, Hundreds of Remedies, Craftsmanship in Smart Manufacturing, Guarding Animal Health.
 

High Automation, Diverse Formulations, Advanced Process, and Stable Quality

Our manufacturing facilities feature:
 High automation with segregated production lines to prevent cross-contamination
 Fully enclosed, dust-free powder production lines with pneumatic material transfer and automated control systems
 Three-story vertical layout optimizing product quality control
 Integrated and automatic injection production lines for washing, drying, filling, capping, and packaging
 Robotic systems for oral solution and powder production, ensuring precision and efficiency

Comprehensive Product Portfolio

KDN offers a wide range of veterinary solutions:
 Chemical drugs, traditional Chinese medicine, feed additives, premixes, disinfectants, and insecticides
 Over 100 approved drug products covering digestive, respiratory, antiviral, disinfectant, antiparasitic, and nutritional categories
 Over 40 registered feed additive products. Target species include poultry, livestock, fur animals, aquatic species, and companion animals

Innovative Formulation Technologies

Our R&D center focuses on:
 Developing new veterinary drugs using advanced formulation technologies
 Recent achievements include 3 new veterinary drugs, 6 high-quality generic drugs, and over 20 process improvements for conventional drugs
 Enhancing drug efficacy and addressing evolving market needs

Antibiotic Sensitization and Resistance Modulation

We are dedicated to:
 Researching drug sensitization and resistance modulation technologies
 Establishing systematic strategies and evaluation methods for antibiotic resistance management
 Developing application solutions to enhance the efficacy of critical antibiotics
 Clinical validation and commercialization of our proprietary resistance modulation technologies, positioning us at the forefront of international innovation in this field

Certificates

Qingdao Vland Animal Health Group Co., Ltd. currently has 32 approved licence numbers, 1 Class II new veterinary drug certificate, 9 Class III new veterinary drug certificates, and 13 invention patents.

Qingdao KDN Animal Pharmaceutical Co., Ltd. currently has over 100 approved drug licence numbers, more than 40 recorded additive products, 34 new veterinary drug certificates, 18 achievement appraisals, 17 invention patents, and 3 scientific and technological awards.
0+
Approved licence numbers
0+
Class II new veterinary drug certificate
0+
Class III new veterinary drug certificates
0+
Invention patents
0+
Approved drug licence numbers
0+
Invention patents
0+
Achievement appraisals
0+
Scientific and technological awards
   +86-15192582183
   +86-0532-68680592
   No.85 Keyun Road, Qingdao High-Tech Zone, Chengyang District, Qingdao City, Shandong Province, China

Quick Links

Products

Copyright © 2025 Vland Animal Health All Rights Reserved. Sitemap. Privacy Policy.
Contact Us